Management of a patient with stage IIIA (N2) NSCLC.
The appropriate treatment of patients with stage IIIA (N2) nonsmall-cell lung cancer (NSCLC) is unclear. With this case report and review, we address the history, assessment, and management of a 67-year-old patient with this diagnosis, and then discuss the challenges in managing N2 disease, as well as the roles of systemic therapy, surgery, and postoperative radiation therapy.
Department of Hematology and Medical Oncology, Emory University, School of Medicine, Emory Winship Cancer Institute, Atlanta, Georgia 30322, USA.
Kathryn
K
Carlson
B Zach
BZ
Fowler
Daniel L
DL
Miller
Anthony
A
Gal
Suresh
S
Ramalingam
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy*; D008197:Lymph Node Excision; D008297:Male; D020360:Neoadjuvant Therapy; D011013:Pneumonectomy; D018714:Radiotherapy, Adjuvant; D020775:Thoracic Surgery, Video-Assisted